Cargando…
Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment
Cancer-associated fibroblasts (CAFs) and myeloma cells could mutually drive myeloma progression, indicating that drug delivery to kill both CAFs and myeloma cells simultaneously could achieve better therapeutic benefits than to kill each cell type alone. Here, we designed a dual-targeting drug deliv...
Autores principales: | Wang, Honglan, Liu, Huiwen, Sun, Chunyan, Liu, Chunying, Jiang, Ting, Yin, Yanxue, Xu, Aoshuang, Pang, Zhiqing, Zhang, Bo, Hu, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922689/ https://www.ncbi.nlm.nih.gov/pubmed/33670464 http://dx.doi.org/10.3390/pharmaceutics13020274 |
Ejemplares similares
-
SAT255 Dual Cause Of Hypercalcemia: Can Both Multiple Myeloma And Paraneoplastic Parathyroid-related Hormone Production Occur Simultaneously?
por: Shah, Anvay, et al.
Publicado: (2023) -
Cytokine nanosponges suppressing overactive macrophages and dampening systematic cytokine storm for the treatment of hemophagocytic lymphohistiocytosis
por: Wang, Honglan, et al.
Publicado: (2022) -
Triphenotypic multiple myeloma expressing kappa or lambda light chain or both
por: Liu, Yang, et al.
Publicado: (2013) -
Both Methylation and Copy Number Variation Participated in the Varied Expression of PRAME in Multiple Myeloma
por: Yang, Lu, et al.
Publicado: (2020) -
Multiple myeloma with simultaneous cutaneous and central nervous system involvement
por: Nguyen, James, et al.
Publicado: (2018)